BioForward names Mailick to board of directors
BioForward, a member-driven state association and the independent voice of Wisconsin’s bio-health industry, today announced several new additions to its board of directors, including Marsha Mailick, vice chancellor for research and graduate education at the University of Wisconsin–Madison.
“It’s an exciting time of growth and collaborative potential in health care and the biosciences in Wisconsin,” says BioForward CEO Lisa Johnson. “Our new board members, coupled with our re-energized efforts across the state, set the stage for a very positive and collaborative 2016.”
The new board members were voted on and approved by BioForward membership for the 2016-18 term at this week’s annual meeting at the Wisconsin Institutes for Discovery on the UW–Madison campus.
“Our state is at a critical inflection point. There is tremendous untapped potential to collaborate and tell our story to stakeholders around the world,” says Joe Hammer, chairman of BioForward and managing director at Capital One Healthcare. “I am excited to start working with our distinguished new directors and thank them for their commitment to our industry.”
BioForward is the leading independent bio-health industry association in the state. Earlier this year, it released an economic development report showing that Wisconsin’s bioscience industry represents $27 billion in total economic output, 36,000 jobs statewide, and nearly $1 billion in funding from National Institutes of Health and other sources.